Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

The study concluded that neonatal occipital alopecia is common, not caused by physical friction, and usually resolves on its own without treatment.

Environmental factors like temperature and nutrition affect hair growth, with humans showing seasonal hair growth differences.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

Exposure to particulate matter worsens postpartum hair loss by affecting inflammation and cell death pathways.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Hair loss peaks in spring and regrowth in late summer, with pregnant females losing the most hair.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

Pregnancy can cause more body and scalp hair growth and make nails brittle, but these changes often revert after giving birth.

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Targeting specific GABA receptors may help treat epilepsy and postpartum depression.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

Pregnancy affects fear memory and brain activity in female rats.

Bullous pyoderma gangrenosum can develop on cesarean scars and may require steroids for treatment.

Blocking progesterone metabolism can cause depression-like behavior in mice.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Higher 3α,5α-THP levels in the brain may reduce depression in pregnant rats.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Selecting Angus cattle for earlier puberty lowers prolactin levels but doesn't affect hair growth.

Sex hormones affect dog skin conditions, but more data is needed.